Login

Financial Snapshot

Revenue
TTM
$107.1M
Gross Margin
TTM
51.01%
Net Income
TTM
-$46.75M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
171.26%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$35.85M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$10.76M

Stock Price

Loading...
Market Cap: $152.26 Million

About Owlet Inc

Owlet Inc (NYSE: OWLT) is a consumer health technology company that develops wearable monitors and software services for infant care. Revenue comes from sales of hardware devices and a subscription-based app that converts physiological data into sleep and wellness guidance for parents. The Dream Sock and Dream Duo are the primary hardware products, providing over-the-counter, medically certified pulse rate and oxygen saturation monitoring with real-time Health Notifications and Live Health Readings. Software services layer on top of hardware through a subscription app, developed and enhanced at a cost of $943 thousand in FY2025 and $761 thousand in FY2024. Total revenues grew from $78.1 million in FY2024 to $105.7 million in FY2025, while the company posted a net loss of $39.7 million in FY2025 versus $12.5 million in FY2024. Owlet holds 63 issued patents and 61 registered trademarks as of February 27, 2026, with core wireless infant monitoring patents expiring in 2033 and additional sensing technology patents extending into the 2040s. Manufacturing is handled by contract partners Benchmark and Shenzhen Aoni Electronic Co.

Revenue model
Owlet generates revenue through hardware device sales (Dream Sock, Dream Duo) and a subscription-based software app. The app provides personalized sleep and health insights drawn from pediatric datasets. FY2025 total revenues were $105.7 million; FY2024 revenues were $78.1 million.
Products and services
Dream Sock: wearable infant sock monitor measuring pulse rate and oxygen saturation, delivering Health Notifications and Live Health Readings. Dream Duo: a combined hardware product including sock-based sensor features. Subscription app: software service providing sleep trend analysis, health pattern insights, and personalized parental guidance built on a pediatric dataset.
Customers and end markets
End customers are parents and caregivers of infants seeking at-home health monitoring. The end market is consumer infant wellness and digital parenting. No customer concentration disclosures were included in the excerpts reviewed.
Value-chain role
Owlet is a branded product and software company that designs medically certified consumer wearables and owns the related IP. Physical manufacturing is outsourced to Benchmark (exclusive manufacturing rights for Dream Sock and Dream Duo through May 31, 2027) and Shenzhen Aoni Electronic Co. Owlet controls product design, IP, software platform, and go-to-market.
Geographic exposure
Owlet has patents and patent applications pending in the European region (EU and United Kingdom), Australia, Brazil, Canada, China, India, Mexico, South Africa, Thailand, and Vietnam, indicating international commercial or IP activity. Primary operating geography is not separately broken out in the excerpts provided.

Source: SEC 10-K, filed 2026-03-09

Industry: Measuring & Controlling Devices, NEC Peers: Abbott Laboratories Accelerate Diagnostics, Inc ASENSUS SURGICAL, INC. Co-Diagnostics Inc CVRx Inc KORU Medical Systems Inc RetinalGenix Technologies Inc Tactile Systems Technology Inc Stereotaxis Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support